跳到内容
Systemic Treatment of Prostate Cancer 预览资料
关闭预览资料
正在查...

Systemic Treatment of Prostate Cancer

著者: Alan Horwich
出版商: Oxford : OUP Oxford, 2010.
丛书: Oxford oncology library.
版本/格式:   电子图书 : 文献 : 英语查看所有的版本和格式
数据库:WorldCat
提要:
Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is  再读一些...
评估:

(尚未评估) 0 附有评论 - 争取成为第一个。

主题
更多类似这样的

 

在线查找

与资料的链接

在图书馆查找

&AllPage.SpinnerRetrieving; 正在查找有这资料的图书馆...

详细书目

类型/形式: Electronic books
附加的形体格式: Print version:
Horwich, Alan.
Systemic Treatment of Prostate Cancer.
Oxford : OUP Oxford, ©2010
材料类型: 文献, 互联网资源
文件类型: 互联网资源, 计算机文档
所有的著者/提供者: Alan Horwich
ISBN: 9780191575815 019157581X 1283348330 9781283348331
OCLC号码: 763157034
描述: 1 online resource (102 pages).
内容: Biological principles of hormone therapy --
PSA as a marker of progression and response in advanced prostate cancer --
Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer --
Systemic treatment of recurrence after local therapies --
First-line hormone therapy for metastatic prostate cancer --
Second- and third-line hormone therapies --
Chemotherapy for metastatic prostate cancer --
Role of bisphosphonates in the systemic treatment of prostate cancer --
Systemic isotope therapy of bone metastasis --
Biological targets and new drug development for prostate cancer.
丛书名: Oxford oncology library.

摘要:

Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause r.

评论

用户提供的评论
正在获取GoodReads评论...
正在检索DOGObooks的评论

标签

争取是第一个!

相似资料

确认申请

你可能已经申请过这份资料。如果还是想申请,请选确认。

链接数据


<http://www.worldcat.org/oclc/763157034>
library:oclcnum"763157034"
library:placeOfPublication
library:placeOfPublication
rdf:typeschema:Book
rdf:typeschema:MediaObject
rdf:valueUnknown value: dct
schema:about
schema:about
<http://id.worldcat.org/fast/1079496>
rdf:typeschema:Intangible
schema:name"Prostate--Cancer--Treatment"@en
schema:name"Prostate--Cancer--Treatment."@en
schema:about
schema:about
schema:about
schema:about
<http://id.worldcat.org/fast/1079483>
rdf:typeschema:Intangible
schema:name"Prostate--Cancer--Diagnosis"@en
schema:name"Prostate--Cancer--Diagnosis."@en
schema:about
schema:about
schema:bookFormatschema:EBook
schema:creator
schema:datePublished"2010"
schema:description"Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause r."@en
schema:description"Biological principles of hormone therapy -- PSA as a marker of progression and response in advanced prostate cancer -- Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer -- Systemic treatment of recurrence after local therapies -- First-line hormone therapy for metastatic prostate cancer -- Second- and third-line hormone therapies -- Chemotherapy for metastatic prostate cancer -- Role of bisphosphonates in the systemic treatment of prostate cancer -- Systemic isotope therapy of bone metastasis -- Biological targets and new drug development for prostate cancer."@en
schema:exampleOfWork<http://worldcat.org/entity/work/id/412274331>
schema:genre"Electronic books"@en
schema:inLanguage"en"
schema:isPartOf
schema:name"Systemic Treatment of Prostate Cancer"@en
schema:publication
schema:publisher
schema:url<http://public.eblib.com/choice/publicfullrecord.aspx?p=797725>
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998>
schema:url<http://www.myilibrary.com?id=334833>
schema:workExample
schema:workExample
wdrs:describedby

Content-negotiable representations

关闭窗口

请登入WorldCat 

没有张号吗?很容易就可以 建立免费的账号.